- March 2, 2023 How Much Protein is Too Much
Geographic Availability Available in all 50 states Clinical Oversight and Safety Licensed, specialized healthcare prescribers issue all GLP-1 prescriptions
The difference becomes more pronounced with higher-dose injectable semaglutide: Wegovy (2.4 mg weekly) demonstrated mean weight loss of approximately 15% of body weight in the STEP clinical trial program for obesity management, substantially exceeding outcomes typically seen with oral semaglutide at diabetes-approved doses
However, the quality of this evidence is constrained by several factors: it stems from a single randomized controlled trial, features an industry-sponsored, open-label design, involves a short follow-up duration, lacks data on muscle preservation, and exclusively includes subjects from a single ethnic population (Chinese)
Wilson, E
In addition, hematochezia tends to cause more minor bleeding than melena does
